Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

A progressive neurological disorder affecting 10 million people globally, Parkinson’s can cause disruptive symptoms such as ...

The study, carried out by experts from the University of Nottingham, found that there was nearly a 50% increased risk of ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

A recent phase 2 clinical trial reveals that Ambroxol, a common cough medicine, shows promise in stabilizing psychiatric ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

A team of neuroscientists in Australia has found that restoring copper levels in the brain dramatically reduced Parkinson-like damage in mice. The approach restored a protein’s function, and the same ...

The company completed a clinical trial at nine centers across the U.S., Europe and Asia before it received FDA approval.

Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...